Bioinformatics Analyst currently employed at Oxford Nanopore Technologies (May 2024 – present), working specifically in the BioPharma market providing quality analysis for both our mRNA vaccine quality control and plasmid quality control workflows. I also work providing quality analysis for AmPORE-TB – an end-to-end workflow using Nanopore sequencing for rapid characterisation of antimicrobial resistance mutations in suspected Mycobacterium tuberculosis samples. Quality control analysis of these end-to-end workflows involves following GAMP5 documentation to ensure regulatory compliance, and maintaining adherence to IEC-62304 guidelines for the lifecycle of medical device software. I currently use the following tools: JAMA, Jira and GitLab, and all documentation is completed using Master Control.
Previously, I successfully defended my PhD thesis in February 2025 from the University of Edinburgh (September 2020 – May 2024), which focused on using pangenomics approaches to analyse meiotic recombination events and refine meiotic recombination breakpoints in African trypanosomes. I optimised this pipeline end-to-end, from initial parasite culture to data analysis, including whole genome assembly, variant calling and pangenome generation.
PhD Project: Analysing the Impact of Sexual Recombination on the Segregation of Virulence Genes in African trypanosomes
Lab techniques:
Bioinformatics techniques:
Other Relevant Skills:
Drug Metabolism
Professor Charles Lacey
Professor Sally Roberts
Soft Skills & Additional Roles / Experience